Celldex Therapeutics, Inc. · DUS:TCE2
Celldex Therapeutics, Inc. shareholders
As of Sep 30, 2026, 241 institutions reported holding Celldex Therapeutics, Inc. Largest: Wellington, Fidelity and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Celldex Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Wellington | 10.7M | +1.13M | Nov 16, 2026 | |
| Fidelity | 8.64M | +4.91M | Nov 10, 2026 | |
| BlackRock | 6.95M | −54,159 | Nov 13, 2026 | |
| Kynam Capital Management, LP | 5.07M | −257K | Nov 16, 2026 | |
| Vanguard | 5.04M | +57,797 | Nov 13, 2026 | |
| T. Rowe Price | 4.39M | −299K | Nov 16, 2026 | |
| State Street | 3.48M | −422K | Nov 12, 2026 | |
| Baker Bros. Advisors LP | 2.56M | +1.38M | Nov 16, 2026 | |
| Deep Track Capital, LP | 2.13M | −814K | Nov 16, 2026 | |
| Geode Capital | 2.05M | +27,116 | Nov 6, 2026 |